This is a medicine called Isentress. It's used to treat HIV infection. It works by blocking an enzyme that HIV needs to copy itself. It's usually taken as a pill, often with other medicines.
Every report comes from a Lived member, sent anonymously.
Have you tried Isentress (Raltegravir) for HIV Infection?
Raltegravir, sold under the brand names Isentress and Isentress HD, is a prescription medicine for HIV-1, the most common type of human immunodeficiency virus. It is approved for adults and for children who weigh at least 2 kg (about 4.4 pounds). Isentress HD, the once-daily version, is limited to adults and children weighing at least 40 kg (about 88 pounds). Generic raltegravir tablets are also available in the US. Raltegravir is always taken together with other HIV medicines, never on its own. This combination approach, called antiretroviral therapy, keeps the virus from multiplying. Treatment does not cure HIV, but by keeping the amount of virus in the blood very low, it lowers the chance of developing AIDS (acquired immunodeficiency syndrome, the advanced stage of HIV) and HIV-related illnesses and reduces the risk of passing HIV to others.
HIV reproduces by inserting a copy of its genetic material into the DNA of the immune cells it infects. Once that copy is built in, the cell becomes a factory for new virus. The virus uses an enzyme called integrase to do the inserting. Raltegravir blocks integrase, so the viral genetic material cannot be built into the cell's DNA and the cell does not go on to produce new virus. This places raltegravir in a drug family called integrase strand transfer inhibitors, or INSTIs. Combining it with medicines that block HIV at other steps makes it much harder for the virus to escape treatment.
For adults, raltegravir comes as a 400 mg tablet taken twice a day (Isentress) or as a 600 mg tablet taken as two tablets once a day (Isentress HD). The once-daily option is meant for people starting HIV treatment for the first time or who are already doing well on the twice-daily form. People who have taken other HIV medicines before and whose virus may be less sensitive to treatment use the twice-daily dose. Either form can be taken with or without food, and the film-coated tablets should be swallowed whole. Children may use chewable tablets or an oral suspension, dosed by weight. These forms are absorbed differently from the film-coated tablets, so they cannot be swapped for them milligram for milligram. Taking every dose on schedule is central to how well raltegravir works. Missed doses let the virus multiply again and can allow it to become resistant, meaning raltegravir and related medicines may stop working against it.
Most people tolerate raltegravir well. The side effects reported most often are trouble sleeping, headache, dizziness, nausea and tiredness. In a large study of people starting treatment, about 5% stopped raltegravir because of side effects over nearly five years, compared with 10% on efavirenz, another HIV medicine. Raltegravir can raise levels of creatine kinase, an enzyme released by damaged muscle, and rare cases of serious muscle breakdown have been reported. Unexplained muscle pain, tenderness or weakness should be reported to the prescriber right away. Severe skin and allergic reactions are rare but can be life-threatening. Any new rash is worth a prompt call to the prescriber. A rash that comes with fever, blisters, mouth sores, red or inflamed eyes, a general ill feeling or yellowing of the skin or eyes means stopping raltegravir and getting medical care right away, because continuing the medicine can make the reaction worse. Trouble breathing or swelling of the face, lips or mouth needs emergency care.
Antacids that contain aluminum or magnesium lower the amount of raltegravir the body absorbs and are not recommended, even when taken several hours apart. Calcium carbonate antacids are acceptable with twice-daily Isentress but not with once-daily Isentress HD. Rifampin, an antibiotic used for tuberculosis, speeds up the breakdown of raltegravir. Adults who need both usually take a higher twice-daily raltegravir dose, and Isentress HD is not recommended with rifampin. Some seizure medicines, including carbamazepine, phenobarbital and phenytoin, may also lower raltegravir levels (their effect has not been studied) and are not recommended with raltegravir. People with a history of muscle breakdown, or who take medicines that can affect muscles, such as statins (cholesterol medicines), fenofibrate or gemfibrozil (medicines that lower triglycerides, a type of blood fat) or the HIV medicine zidovudine, should make sure the prescriber knows. Raltegravir has fewer interactions than many HIV medicines, but a full list of prescriptions, over-the-counter products and supplements should still be reviewed. Pregnancy registry data from several hundred pregnancies have not shown a higher rate of birth defects with raltegravir, though information on the once-daily dose in pregnancy is limited. The prescribing information advises against breastfeeding because HIV can pass to a baby through breast milk, so infant feeding is worth planning with the HIV care team. The chewable tablets contain a small amount of phenylalanine, which matters for people with phenylketonuria (PKU), an inherited condition in which the body cannot break down phenylalanine.
The goal of treatment is an undetectable viral load, meaning the amount of HIV in the blood is too low for standard tests to measure. The care team checks viral load and CD4 count (a measure of the immune cells HIV attacks) after starting treatment and then regularly, to confirm the medicines are working. Most people take HIV medicines for life, because the virus returns if treatment stops. In the first weeks or months, as the immune system recovers, it can react strongly to infections that were already in the body, sometimes causing fever or other new symptoms. This is called immune reconstitution syndrome and is more likely in people who started treatment with advanced HIV. New or returning signs of infection during this period should be reported promptly. The main day-to-day consideration is the dosing schedule. Some people find the once-daily form easier to fit into routines, while the twice-daily form is needed in certain situations, such as prior treatment experience or taking rifampin.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Isentress (Raltegravir), what you've noticed, or ask the community a question.